YOMOGI Slovensko - slovenčina - ŠÚKL (Štátny ústav pre kontrolu liečiv)

yomogi

ardeypharm gmbh pharmazeutische fabrik, nemecko - saccharomyces boulardii - 49 - digestiva, adsorbentia, acida

Heplisav B Európska únia - slovenčina - EMA (European Medicines Agency)

heplisav b

dynavax gmbh - povrchový antigén hepatitídy b - Žltačka typu b - vakcíny - heplisav b is indicated for the active immunisation against hepatitis b virus infection (hbv) caused by all known subtypes of hepatitis b virus in adults 18 years of age and older. the use of heplisav b should be in accordance with official recommendations. it can be expected that hepatitis d will also be prevented by immunisation with heplisav b as hepatitis d (caused by the delta agent) does not occur in the absence of hepatitis b infection.